Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Longer Duration of Palliative Care in Patients With COPD Is Associated With Death Outside the Hospital.

Kraskovsky V, Schneider J, Mador MJ, Provost KA.

J Palliat Care. 2019 Jul 2:825859719851486. doi: 10.1177/0825859719851486. [Epub ahead of print]

PMID:
31262230
2.

Bacterial regulation of macrophage bacterial recognition receptors in COPD are differentially modified by budesonide and fluticasone propionate.

Provost KA, Smith M, Miller-Larsson A, Gudleski GD, Sethi S.

PLoS One. 2019 Jan 24;14(1):e0207675. doi: 10.1371/journal.pone.0207675. eCollection 2019.

3.

Genomic divergence in allopatric Northern Cardinals of the North American warm deserts is linked to behavioral differentiation.

Provost KL, Mauck WM 3rd, Smith BT.

Ecol Evol. 2018 Dec 11;8(24):12456-12478. doi: 10.1002/ece3.4596. eCollection 2018 Dec.

4.

Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial.

Couturaud F, Pernod G, Presles E, Duhamel E, Jego P, Provost K, Pan-Petesch B, Sollier CBD, Tromeur C, Hoffmann C, Bressollette L, Lorillon P, Girard P, Le Moigne E, Le Hir A, Guégan M, Laporte S, Mismetti P, Lacut K, Bosson JL, Bertoletti L, Sanchez O, Meyer G, Leroyer C, Mottier D; “PADIS-DVT” investigators.

Haematologica. 2019 Jul;104(7):1493-1501. doi: 10.3324/haematol.2018.210971. Epub 2019 Jan 3.

5.

Investigation of the local structure of nanosized rhodium hydride.

Zlotea C, Blondeau L, Malouche A, Bourgon J, Provost K, Morfin F, Piccolo L.

J Colloid Interface Sci. 2018 Aug 15;524:427-433. doi: 10.1016/j.jcis.2018.04.047. Epub 2018 Apr 11.

PMID:
29677611
6.

Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial.

Tromeur C, Sanchez O, Presles E, Pernod G, Bertoletti L, Jego P, Duhamel E, Provost K, Parent F, Robin P, Deloire L, Leven F, Mingant F, Bressollette L, Le Roux PY, Salaun PY, Nonent M, Pan-Petesch B, Planquette B, Girard P, Lacut K, Melac S, Mismetti P, Laporte S, Meyer G, Mottier D, Leroyer C, Couturaud F; PADIS-PE Investigators18.

Eur Respir J. 2018 Jan 4;51(1). pii: 1701202. doi: 10.1183/13993003.01202-2017. Print 2018 Jan.

7.

Reproducibility of Lobar Perfusion and Ventilation Quantification Using SPECT/CT Segmentation Software in Lung Cancer Patients.

Provost K, Leblond A, Gauthier-Lemire A, Filion É, Bahig H, Lord M.

J Nucl Med Technol. 2017 Sep;45(3):185-192. doi: 10.2967/jnmt.117.191056. Epub 2017 Apr 13.

8.

Composition and size dependence of hydrogen interaction with carbon supported bulk-immiscible Pd-Rh nanoalloys.

Oumellal Y, Provost K, Ghimbeu CM, de Yuso AM, Zlotea C.

Nanotechnology. 2016 Nov 18;27(46):465401. Epub 2016 Oct 17.

PMID:
27749273
9.

Detection of Intrathoracic Bleeding by 99mTc-Labeled Red Blood Cell SPECT/CT After Wedge Biopsy of Pulmonary Angiosarcoma.

Provost K, Charest M.

J Nucl Med Technol. 2016 Sep;44(3):205-6. doi: 10.2967/jnmt.116.174235. Epub 2016 Jun 30.

10.

Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.

Couturaud F, Sanchez O, Pernod G, Mismetti P, Jego P, Duhamel E, Provost K, dit Sollier CB, Presles E, Castellant P, Parent F, Salaun PY, Bressollette L, Nonent M, Lorillon P, Girard P, Lacut K, Guégan M, Bosson JL, Laporte S, Leroyer C, Décousus H, Meyer G, Mottier D; PADIS-PE Investigators.

JAMA. 2015 Jul 7;314(1):31-40. doi: 10.1001/jama.2015.7046.

PMID:
26151264
11.

Calcium restores the macrophage response to nontypeable haemophilus influenzae in chronic obstructive pulmonary disease.

Provost KA, Smith M, Arold SP, Hava DL, Sethi S.

Am J Respir Cell Mol Biol. 2015 Jun;52(6):728-37. doi: 10.1165/rcmb.2014-0172OC.

PMID:
25338285
13.

EXAFS Debye-Waller factors issued from Car-Parrinello molecular dynamics: application to the fit of oxaliplatin and derivatives.

Provost K, Beret EC, Bouvet Muller D, Michalowicz A, Sánchez Marcos E.

J Chem Phys. 2013 Feb 28;138(8):084303. doi: 10.1063/1.4790516.

PMID:
23464147
14.

Maternal serum hormonal factors in the pathogenesis of preeclampsia.

Salustiano EM, De Pinho JC, Provost K, Ruano R, Zugaib M.

Obstet Gynecol Surv. 2013 Feb;68(2):141-50. doi: 10.1097/OGX.0b013e31827f2500. Review.

PMID:
23417220
15.

Hemocytes are sites of enteric virus persistence within oysters.

Provost K, Dancho BA, Ozbay G, Anderson RS, Richards GP, Kingsley DH.

Appl Environ Microbiol. 2011 Dec;77(23):8360-9. doi: 10.1128/AEM.06887-11. Epub 2011 Sep 23.

16.

IFN-γ acts on the airway epithelium to inhibit local and systemic pathology in allergic airway disease.

Mitchell C, Provost K, Niu N, Homer R, Cohn L.

J Immunol. 2011 Oct 1;187(7):3815-20. doi: 10.4049/jimmunol.1100436. Epub 2011 Aug 26.

17.

Coupling CP-MD simulations and X-ray absorption spectroscopy: exploring the structure of oxaliplatin in aqueous solution.

Beret EC, Provost K, Müller D, Marcos ES.

J Phys Chem B. 2009 Sep 10;113(36):12343-52. doi: 10.1021/jp905415v.

PMID:
19685899
18.

EXAFS structural study of platinum-based anticancer drugs degradation in presence of sulfur nucleophilic species.

Provost K, Bouvet-Muller D, Crauste-Manciet S, Moscovici J, Olivi L, Vlaic G, Michalowicz A.

Biochimie. 2009 Oct;91(10):1301-6. doi: 10.1016/j.biochi.2009.07.005. Epub 2009 Jul 14.

PMID:
19607872
19.

[Prolongation of anti vitamin K treatment for 18 months versus placebo after 6 months treatment of a first episode of ideopathic pulmonary embolism: a mutlicentre, randomised double blind trail. The PADIS-EP Trial].

Couturaud F, Pernod G, Pison C, Mismetti P, Sanchez O, Meyer G, Parent F, Girard P, Simonneau G, Drouet L, Gueret P, Jego P, Delaval P, Duhamel E, Gruel Y, Delahousse B, Regina S, Pottier P, Connaud J, Lecomte F, Provost K, Vilmans N, Gosset X, Bura-Rivière A, Meach G, Lacut K, Bosson JL, Guillot K, Mottier D, Leroyer C.

Rev Mal Respir. 2008 Sep;25(7):885-93. French.

PMID:
18946418
20.

EXAFS characterization of oxaliplatin anticancer drug and its degradation in chloride media.

Bouvet D, Michalowicz A, Crauste-Manciet S, Curis E, Nicolis I, Olivi L, Vlaic G, Brossard D, Provost K.

J Synchrotron Radiat. 2006 Nov;13(Pt 6):477-83. Epub 2006 Oct 18.

PMID:
17057326
21.

EXAFS and IR structural study of platinum-based anticancer drugs' degradation by diethyl dithiocarbamate.

Bouvet D, Michalowicz A, Crauste-Manciet S, Brossard D, Provost K.

Inorg Chem. 2006 Apr 17;45(8):3393-8.

PMID:
16602799
22.
23.

F-test in EXAFS fitting of structural models.

Michalowicz A, Provost K, Laruelle S, Mimouni A, Vlaic G.

J Synchrotron Radiat. 1999 May 1;6(Pt 3):233-5. Epub 1999 May 1. No abstract available.

PMID:
15263260
24.

Carboplatin and oxaliplatin decomposition in chloride medium, monitored by XAS.

Curis E, Provost K, Bouvet D, Nicolis I, Crauste-Manciet S, Brossard D, Bénazeth S.

J Synchrotron Radiat. 2001 Mar 1;8(Pt 2):716-8.

PMID:
11512906
25.

CRYSTALFF--from crystallography to EXAFS multiple-scattering calculations with FEFF.

Provost K, Champloy F, Michalowicz A.

J Synchrotron Radiat. 2001 Jul 1;8(4):1109-12.

PMID:
11486363
26.

Synthesis, crystal structure, EXAFS, and magnetic properties of catena [mu-tris(1,2-bis(tetrazol-1-yl)propane-N1,N1')iron(II)] bis(perchlorate). First crystal structure of an iron(II) spin-crossover chain compound.

van Koningsbruggen PJ, Garcia Y, Kahn O, Fournès L, Kooijman H, Spek AL, Haasnoot JG, Moscovici J, Provost K, Michalowicz A, Renz F, Gütlich P.

Inorg Chem. 2000 May 1;39(9):1891-900.

PMID:
11428109
27.

Intermittent left coronary occlusion caused by native aortic valve thrombosis in a patient with protein S deficiency.

Jobic Y, Provost K, Larlet JM, Mondine P, Gilard M, Boschat J, Blanc JJ.

J Am Soc Echocardiogr. 1999 Dec;12(12):1114-6.

PMID:
10588791
28.

Lysozyme crystal growth, as observed by small angle X-ray scattering, proceeds without crystallization intermediates.

Finet S, Bonneté F, Frouin J, Provost K, Tardieu A.

Eur Biophys J. 1998;27(3):263-71.

PMID:
9615398
29.

[Myocardial infarction caused by acute left main coronary artery occlusion. Apropos of 4 cases and review of the literature].

Gilard M, Bouquin V, Boschat J, Provost K, Jobic Y, Larlet JM, Guillo P, Blanc JJ.

Arch Mal Coeur Vaiss. 1997 Sep;90(9):1277-83. Review. French.

PMID:
9488775
30.

Long-term prognosis in patients with alcoholic cardiomyopathy and severe heart failure after total abstinence.

Guillo P, Mansourati J, Maheu B, Etienne Y, Provost K, Simon O, Blanc JJ.

Am J Cardiol. 1997 May 1;79(9):1276-8.

PMID:
9164905
31.

[Endocoronary ultrasonography and quantitative coronary angiography. Correlations before and after transluminal coronary angioplasty].

Boschat J, Matteodo K, Gilard M, Larlet JM, Provost K, Jobic Y, Guillo P, Etienne Y, Mansourati J, Blanc JJ.

Arch Mal Coeur Vaiss. 1997 Mar;90(3):353-60. French.

PMID:
9232073
32.

Main structural and functional features of the basic cytosolic bovine 21 kDa protein delineated through hydrophobic cluster analysis and molecular modelling.

Schoentgen F, Seddiqi N, Bucquoy S, Jollès P, Lemesle-Varloot L, Provost K, Mornon JP.

Protein Eng. 1992 Jun;5(4):295-303.

PMID:
1409551
33.

Taking the "mystery" out of inconsistent qualitative results for choriogonadotropin.

Provost KL, Longley WJ.

Clin Chem. 1984 Jun;30(6):1108-9. No abstract available.

34.

Photoaffinity reagents for use with pepsin and other carboxyl proteases.

Hixson SH, Hurwitz JL, Langridge KJ, Nichols DC, Provost KM, Wolff AM.

Biochem Biophys Res Commun. 1983 Mar 16;111(2):630-5.

PMID:
6404274
35.

Antibodies directed against a gamma-carboxyglutamic acid-rich region of bovine prothrombin. Preparation, isolation, and characterization.

Furie B, Provost KL, Blanchard RA, Furie BC.

J Biol Chem. 1978 Dec 25;253(24):8980-7. No abstract available.

Supplemental Content

Loading ...
Support Center